Three new IPOs are scheduled for the week of June 10th. The full IPO calendar is here.
Ranked by size of IPO.
Based in New York, NY, Coty scheduled a $1 billion IPO with a market capitalization of $6.7 billion at a price range mid-point of $17.50 for Thursday, June 13, 2013.
COTY's beauty products portfolio includes very well-known names. The COTY IPO is a shareholder bailout with no proceeds going to the company.
COTY has a spotty financial record, in terms of sales and profits, and will be offering a dividend lower than its competition. Revenue was flat for the March '13 nine months vs. the March '12 nine months, at $3.5 billion.
Based in Milpitas, CA, Gigamon scheduled a $128 IPO with a market capitalization of $561, at a price range mid-point of $19 for Wednesday, June 12, 2013.
GIMO's sales are increasing at a much faster rate than its bigger competitors: 2012 revenue was up 43% to $97 million for 2012 vs. 2011. Revenue was up 53% to $26 from $17 for Q1 '13 vs. Q1 '12.
Aratana Therapeutics (NASDAQ:PETX)
Based in Kansas City, KS, Aratana Therapeutics scheduled a $51 IPO with a market capitalization of $216 at a price range mid-point of $12 for Thursday, June 13, 2013.
7Since founding in 2010, PETX has licensed three compounds, AT-001, AT-002 and AT-003, that PETX is developing into six products for use in pets in the United States and Europe.
PETX is still conducting clinical studies and then intends to conduct clinical trials.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.